Page 2 - Stobra News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Bad Sulza gibt Termine für Einwohnerversammlungen bekannt
thueringer-allgemeine.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thueringer-allgemeine.de Daily Mail and Mail on Sunday newspapers.
Bad Sulza: Zwei Verletzte nach Unfall
tlz.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tlz.de Daily Mail and Mail on Sunday newspapers.
Search jobs Immunodiagnostics and Vaccine Development at Viravaxx AG Gain Momentum
Vienna (Austria), Jan 11, 2021. Fast-track development of vaccines against COVID-19 and other infectious diseases are facilitated by microarray-based assays for whole-proteome analysis and vaccine design platforms. Both have been developed by Viravaxx AG, and the company’s recent progress with its SARS-CoV-2 Interaction Assay offered a turning point.
Concomitantly, as of Jan 1, 2021, Viravaxx has recruited Dr. Helmut Brunar as its new CEO. Dr. Brunar brings vast expertise in vaccines, cell-therapies and diagnostic products to the company. Before joining Viravaxx, he managed supply chain activities at Johnson & Johnson’s COVID-19 vaccine program. Prior to this, he was CEO & Chairman with Axentis Pharma AG where he built a team to develop respiratory drug candidate AX-TOBRA. Dr. Brunar will take over from Dr. Rainer Henning, who has made invaluable contributions for